Recombinant Viruses for Cancer Therapy

 Recombinant viruses area unit novel therapeutic agents that may be utilized for treatment of assorted diseases, as well as cancers. Recombinant viruses will be designed to precise foreign transgenes and have a broad reaction permitting organic phenomenon in an exceedingly wide selection of host cells. They can be designed for specific therapeutic goals. The recombinant viruses can be customizes to stimulate host response against tumor-specific antigens so that it can overcome the ability of the tumor to evade the host’s immune surveillance. Alternatively, recombinant viruses might categorical immunomodulatory genes that stimulate associate anti-cancer immune reaction

    Related Conference of Recombinant Viruses for Cancer Therapy

    July 25-26, 2024

    3rd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE

    Recombinant Viruses for Cancer Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in